Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%
Ph phase_1
1
25%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (25.0%)
N/A3 (75.0%)

Trials by Status

completed375%
withdrawn125%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Determining Lipid Content in Stool After Alpha-cyclodextrin

NCT03002168
completednot_applicable

FBCx (Alpha-CD) Mechanism of Action Trial

NCT02999620
withdrawnnot_applicable

The Effect of Oral Alpha-Cyclodextrin on Fecal Fat Excretion

NCT01910558
completedphase_1

Sulforadex in Healthy Human Males MAD

NCT02055716

Clinical Trials (4)

Showing 4 of 4 trials
NCT03002168Not Applicable

Determining Lipid Content in Stool After Alpha-cyclodextrin

Completed
NCT02999620Not Applicable

FBCx (Alpha-CD) Mechanism of Action Trial

Completed
NCT01910558Not Applicable

The Effect of Oral Alpha-Cyclodextrin on Fecal Fat Excretion

Withdrawn
NCT02055716Phase 1

Sulforadex in Healthy Human Males MAD

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4